Absci
Absci60
About
What does Absci do?
Absci leverages generative AI and synthetic biology to discover novel biology and create better biologics. Their AI Drug Creation Platform designs differentiated biologics, such as antibodies targeting prolactin receptors for hair regrowth, and partners with leaders across pharma, tech, and academia to develop therapeutics against challenging targets. Absci aims to accelerate the delivery of life-changing medicines to patients.
What is Absci's revenue?
StartupHub estimates Absci's annual revenue at $41.6M (range $22.2M to $71.6M, 64% confidence), based on comparable companies in the sector.
What is Absci's valuation?
StartupHub estimates Absci's effective valuation at $422.1M (range $251.3M to $603.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Absci raised?
Absci has raised a total of $101M in funding. The most recent round on record is Series C.
Where is Absci headquartered?
Absci is headquartered in Vancouver, United States.
When was Absci founded?
Absci was founded in 2011.
What industry does Absci operate in?
Absci operates in Biotech, Drug Discovery, AI-Driven Protein Design, Foundation Model, Generative AI, Platform.
How many employees does Absci have?
Absci has approximately 173 people on record.
No comments yet. Be the first to share your take.